Labcorp (LH) News
NYSE: LHHealth CareMedical SpecialitiesUSD
312.15-2.05 (-0.65%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LH news summary
We found 3 recent headlines mentioning Labcorp (LH): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, LH is down 0.65% at $312.15. The most recent story, "DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?", was published by Nasdaq on Sep 30, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Labcorp headlines
- DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?Danaher's Biotechnology segment posts 4% sales growth, but tough comparisons and shipment timing could test its momentum.NasdaqDHR, LH, CVS
- Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.NasdaqDHR, LH, CVS
- IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins ImproveIDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.NasdaqIDXX, ABT, LH